Association of Vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients

Jessica Cusato, Lucio Boglione, Amedeo De Nicolò, Rosaria Imbornone, Chiara Simona Cardellino, Valeria Ghisetti, Chiara Carcieri, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: Vitamin D modulates biological processes; an influence of vitamin D levels and genetic variants was identified concerning hepatitis B virus infection. We evaluated the role of some SNPs of vitamin D pathway genes in some clinical features of hepatitis B affected patients treated with pegylated interferon. Methods: We investigated SNPs in IL-28B, CYP27B1, CYP27A1, CYP24A1, VDBP and VDR genes, through real-time PCR. Results: VDRApaI SNP was associated to viral load and HBsAg presence at different timings. In logistic regression analyses, VDRApaI AA genotype predicted baseline viral load >6 Log IU/ml (marker of nonresponse), and both virological and biochemical responses. Conclusion: Pharmacogenetic data could help physicians in the prediction of patients with higher probability to achieve a good response.

Original languageEnglish
Pages (from-to)651-661
Number of pages11
JournalPharmacogenomics
Volume18
Issue number7
DOIs
Publication statusPublished - May 2017
Externally publishedYes

Keywords

  • VDR genes
  • calcitriol
  • pharmacogenetics

Fingerprint

Dive into the research topics of 'Association of Vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients'. Together they form a unique fingerprint.

Cite this